Low utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013-2023).
Joseph FaresRoss SummerGiorgos LoizidisPublished in: Clinical rheumatology (2023)
There is a marked disparity in statin initiation between DM/PM-HLD and RA-HLD patients, accompanied by elevated mortality in DM/PM-HLD non-users. It is imperative for further research to elucidate this discrepancy and formulate patient-centric cardiovascular guidelines for DM/PM-HLD patients. Key Points • Statin initiation among patients with DM/PM-HLD is significantly lower than that with RA-HLD. • Mortality rates within the statin initiator DM/PM-HLD were significantly lower compared to non-statin DM/PM-HLD initiators, spanning multiple time intervals.
Keyphrases
- particulate matter
- air pollution
- end stage renal disease
- cardiovascular disease
- polycyclic aromatic hydrocarbons
- heavy metals
- ejection fraction
- coronary artery disease
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- rheumatoid arthritis
- interstitial lung disease
- prognostic factors
- glycemic control
- insulin resistance
- patient reported outcomes
- systemic sclerosis
- ankylosing spondylitis
- skeletal muscle
- low density lipoprotein
- idiopathic pulmonary fibrosis